Skip to main content

Table 2 Mean signal intensities of various proteins and peptides comparing endometrium of women with a normal pelvis versus endometriosis (CM10 and IMAC)

From: TRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of the same sample in women with and without endometriosis

CM10

   

CHCA

    

M/z

pvalue

Mean Disease

Mean Control

Up/down

14653,82

0,034

0,795

1,468

down

16851,18

0,020

0,378

0,660

down

SPAhigh

    

8776,32

0,020

0,854

0,310

up

8898,40

0,045

4,530

1,935

up

10115,90

0,034

7,442

3,545

up

12186,64

0,026

0,300

0,132

up

12379,95

0,011

2,028

0,420

up

12683,46

0,026

0,988

0,444

up

13464,70

0,045

0,361

0,198

up

14479,03

0,011

0,282

0,116

up

17258,59

0,034

0,370

0,168

up

SPAlow

    

7662,79

0,045

0,247

0,362

down

8949,82

0,026

1,310

0,720

up

9177,29

0,020

0,391

1,381

down

9941,98

0,026

2,221

1,234

up

10084,76

0,045

1,807

1,096

up

11477,23

0,034

0,087

0,167

down

12323,14

0,011

0,652

0,215

up

12623,72

0,045

0,375

0,219

up

IMAC

   

CHCA

 

M/z

pvalue

Mean Disease

Mean Control

Up/down

6299,93

0,011

0,319

0,470

down

9213,51

0,008

0,607

1,578

down

9266,22

0,011

0,933

1,440

down

9766,19

0,034

0,699

0,360

up

11163,87

0,020

0,527

0,245

up

11322,71

0,015

1,017

0,294

up

15446,04

0,004

0,586

0,108

up

SPAhigh

    

9532,42

0,026

3,217

13,993

down

9767,55

0,045

2,180

4,258

down

SPAlow

    

7832,06

0,020

0,205

0,369

down

8228,62

0,004

0,389

0,198

up

9190,05

0,015

0,420

1,406

down

9262,94

0,034

0,900

0,502

up